chronic cutaneous lupus erythematosus difficult management
DESCRIPTION
Chronic Cutaneous Lupus Erythematosus Difficult ManagementTRANSCRIPT
![Page 1: Chronic Cutaneous Lupus Erythematosus Difficult Management](https://reader036.vdocuments.us/reader036/viewer/2022062303/556e070bd8b42aba5d8b4a75/html5/thumbnails/1.jpg)
Chronic Cutaneous Lupus Erythematosus
What would you propose as therapeutic option in this
case?
![Page 2: Chronic Cutaneous Lupus Erythematosus Difficult Management](https://reader036.vdocuments.us/reader036/viewer/2022062303/556e070bd8b42aba5d8b4a75/html5/thumbnails/2.jpg)
Chronic cutaneous LE
63-year-old women. Diagnosed of Chronic Cutaneous
Lupus Erythematosus in 2006.
![Page 3: Chronic Cutaneous Lupus Erythematosus Difficult Management](https://reader036.vdocuments.us/reader036/viewer/2022062303/556e070bd8b42aba5d8b4a75/html5/thumbnails/3.jpg)
Chronic cutaneous LE
Physical examination• Smooth, non scarring, pink to
violaceous papules or plaques without evidence of surface change.
• Loceted on the face and upper extremities.
![Page 4: Chronic Cutaneous Lupus Erythematosus Difficult Management](https://reader036.vdocuments.us/reader036/viewer/2022062303/556e070bd8b42aba5d8b4a75/html5/thumbnails/4.jpg)
Chronic cutaneous LE
Skin Biopsy revealed:• A superficial and deep lymphocytic
infiltration in a perivascular and periadnexal distribution.
• Dermal interstitial mucin deposition and focal or absent dermoepidermal junction involvement.
![Page 5: Chronic Cutaneous Lupus Erythematosus Difficult Management](https://reader036.vdocuments.us/reader036/viewer/2022062303/556e070bd8b42aba5d8b4a75/html5/thumbnails/5.jpg)
Chronic cutaneous LE
Laboratory examinations: Antinuclear antibodies: 1/40.
Homogeneous. Anti SSA/RO: positive.
![Page 6: Chronic Cutaneous Lupus Erythematosus Difficult Management](https://reader036.vdocuments.us/reader036/viewer/2022062303/556e070bd8b42aba5d8b4a75/html5/thumbnails/6.jpg)
Chronic cutaneous LE
![Page 7: Chronic Cutaneous Lupus Erythematosus Difficult Management](https://reader036.vdocuments.us/reader036/viewer/2022062303/556e070bd8b42aba5d8b4a75/html5/thumbnails/7.jpg)
Chronic cutaneous LE
![Page 8: Chronic Cutaneous Lupus Erythematosus Difficult Management](https://reader036.vdocuments.us/reader036/viewer/2022062303/556e070bd8b42aba5d8b4a75/html5/thumbnails/8.jpg)
Chronic cutaneous LE
Treatment was prescribed without improvement in 2006:
Topical tacrolimus, pimecrolimus and corticosteroids.
Hydroxychloroquine at a dose of 400-600 mg/d for 6 months.
Prednisone at a dose of 0,5 mg/kg/d for 3 months.
![Page 9: Chronic Cutaneous Lupus Erythematosus Difficult Management](https://reader036.vdocuments.us/reader036/viewer/2022062303/556e070bd8b42aba5d8b4a75/html5/thumbnails/9.jpg)
Chronic cutaneous LE 2007
![Page 10: Chronic Cutaneous Lupus Erythematosus Difficult Management](https://reader036.vdocuments.us/reader036/viewer/2022062303/556e070bd8b42aba5d8b4a75/html5/thumbnails/10.jpg)
Chronic cutaneous LE 2007
![Page 11: Chronic Cutaneous Lupus Erythematosus Difficult Management](https://reader036.vdocuments.us/reader036/viewer/2022062303/556e070bd8b42aba5d8b4a75/html5/thumbnails/11.jpg)
Chronic cutaneous LE
Treatment was prescribed without improvement in 2007
Dapsone at a dose of 100 mg/d for 8 months.
![Page 12: Chronic Cutaneous Lupus Erythematosus Difficult Management](https://reader036.vdocuments.us/reader036/viewer/2022062303/556e070bd8b42aba5d8b4a75/html5/thumbnails/12.jpg)
Chronic cutaneous LE 2008
![Page 13: Chronic Cutaneous Lupus Erythematosus Difficult Management](https://reader036.vdocuments.us/reader036/viewer/2022062303/556e070bd8b42aba5d8b4a75/html5/thumbnails/13.jpg)
Chronic cutaneous LE
Treatment was prescribed without improvement in 2008-2009.
Methotrexate at a dose of 15mg at week for 4 months.
![Page 14: Chronic Cutaneous Lupus Erythematosus Difficult Management](https://reader036.vdocuments.us/reader036/viewer/2022062303/556e070bd8b42aba5d8b4a75/html5/thumbnails/14.jpg)
Chronic cutaneous LE 2009
![Page 15: Chronic Cutaneous Lupus Erythematosus Difficult Management](https://reader036.vdocuments.us/reader036/viewer/2022062303/556e070bd8b42aba5d8b4a75/html5/thumbnails/15.jpg)
What would you propose as therapeutic
option in this case?
Chronic cutaneous LE
F.Peral Rubio, M.D.
Department of Dermatology Complejo Hospitalario Universitario, Badajoz, Spain.